OpenVSafe by OpenVAERS
Search V-safe

TUD-90238-70212

1 vaccination 2 coded responses 2 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
371 / TN
Registered
2021-11-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1920288 (opens in a new window) high 9 / 11 -3 1 of 6 VAERS symptoms same dose (1) MO differs 2021-09-02 / 2021-09-09 / 2021-12-03
received the same day as the last call
 case 1199456

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-09-02
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-01
    Registered in v-safe
  3. 2021-12-02
    Survey response — 3 months, dose 1
    MedDRA: Abortion spontaneous, Benign hydatidiform mole — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Hospitalization
    Free text: Partial molar pregnancy and miscarriage
    MedDRA releases: 2024-11 · check-in free text available
  4. 2021-12-02
    Report sent to call center — 3 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
  5. 2021-12-03
    Call successful
    Completed over the phone
  6. 2022-03-03
    Survey response — 6 months, dose 1
    MedDRA: Medical procedure, Uterine haemorrhage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: Uterine hemorrhaging · Healthcare visit (other): Procedure
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-03-03
    Report sent to call center — 6 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  8. 2022-03-04
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-09-02Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-12-02 Successful
2021-12-03
 Completed over the phone
2022-03-03 Successful
2022-03-04
 Participant prefers to complete VAERS report online

Free text

Release 10 — 3 months, dose 1

2021-12-02

Symptoms: Partial molar pregnancy and miscarriage

Release 11 — 6 months, dose 1

2022-03-03

Symptoms: Uterine hemorrhaging
Healthcare visit (other): Procedure

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMedical procedure · · ✓
SDAbortion spontaneous · · ✓
SDBenign hydatidiform mole · · ✓
SDUterine haemorrhage · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…